These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33781956)

  • 1. Non-invasive brain stimulation for speech in Parkinson's disease: A randomized controlled trial.
    Brabenec L; Klobusiakova P; Simko P; Kostalova M; Mekyska J; Rektorova I
    Brain Stimul; 2021; 14(3):571-578. PubMed ID: 33781956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation for hypokinetic dysarthria in Parkinson's disease enhances white matter integrity of the auditory-motor loop.
    Brabenec L; Simko P; Sejnoha Minsterova A; Kostalova M; Rektorova I
    Eur J Neurol; 2023 Apr; 30(4):881-886. PubMed ID: 36529528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson's disease.
    Brabenec L; Klobusiakova P; Barton M; Mekyska J; Galaz Z; Zvoncak V; Kiska T; Mucha J; Smekal Z; Kostalova M; Rektorova I
    Parkinsonism Relat Disord; 2019 Apr; 61():187-192. PubMed ID: 30337204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.
    Eliasova I; Mekyska J; Kostalova M; Marecek R; Smekal Z; Rektorova I
    J Neural Transm (Vienna); 2013 Apr; 120(4):597-605. PubMed ID: 23254927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
    Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Articulatory network reorganization in Parkinson's disease as assessed by multimodal MRI and acoustic measures.
    Klobusiakova P; Mekyska J; Brabenec L; Galaz Z; Zvoncak V; Mucha J; Rapcsak SZ; Rektorova I
    Parkinsonism Relat Disord; 2021 Mar; 84():122-128. PubMed ID: 33609963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
    Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
    Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency rTMS over the supplementary motor area improves freezing of gait in Parkinson's disease: a randomized controlled trial.
    Mi TM; Garg S; Ba F; Liu AP; Wu T; Gao LL; Dan XJ; Chan P; McKeown MJ
    Parkinsonism Relat Disord; 2019 Nov; 68():85-90. PubMed ID: 31689588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of speech and language therapy for a case of dysarthria associated with Parkinson's disease.
    Le Dorze G; Dionne L; Ryalls J; Julien M; Ouellet L
    Eur J Disord Commun; 1992; 27(4):313-24. PubMed ID: 1308695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation.
    Murdoch BE; Ng ML; Barwood CH
    Eur J Neurol; 2012 Feb; 19(2):340-7. PubMed ID: 21967191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathomechanisms and compensatory efforts related to Parkinsonian speech.
    Arnold C; Gehrig J; Gispert S; Seifried C; Kell CA
    Neuroimage Clin; 2014; 4():82-97. PubMed ID: 24319656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reception of Communicative Functions of Prosody in Hypokinetic Dysarthria due to Parkinson's Disease.
    Martens H; Van Nuffelen G; Wouters K; De Bodt M
    J Parkinsons Dis; 2016; 6(1):219-29. PubMed ID: 26889630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial.
    Levy ES; Moya-Galé G; Chang YHM; Freeman K; Forrest K; Brin MF; Ramig LA
    EClinicalMedicine; 2020 Jul; 24():100429. PubMed ID: 32639484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.